Lung cancer is one of the most common tumors in the world. It is the leading cause of cancer death among men and women. Smoking causes most lung cancers.
There are many types of lung cancer . Each of them grows and spreads in a different way. Treatment also depends on the stage or how advanced it is.
Common symptoms of lung cancer include:
Treatment for lung cancer in Cuba with therapeutic vaccines, CIMAvax-EGFhr and Vaxira are indicated for patients who have already undergone chemotherapy or radiotherapy and are considered terminal without therapeutic alternative, controlling tumor growth without associated toxicity and increasing the expectation and quality of life of patients.
Treatment with these therapeutic vaccines can contribute to significantly prolonging the life span of patients and improving their quality of life, bringing the fatal course of this disease closer to the course of chronic non-communicable diseases.
It is important to note that the drug does not prevent disease like a traditional vaccine.
The action of these lung cancer vaccines does not allow lung tumors to continue to develop, acting more like a treatment. Known as a therapeutic vaccine, rather than targeting cancer cells directly, the vaccine acts as a form of immunotherapy, harnessing the body's own immune system to fight cancer.
Very little adverse reaction has been seen, perhaps tremors for about five minutes. We recommend that the patient not touch the area, massage, or scratch.
The lung cancer vaccine is applied in the La Pradera International Health Center .
This therapy is indicated in those patients with non-small cell lung tumors, in advanced stages, who have completed the first line of oncospecific therapy, at least 4 weeks before.
The results that have been obtained since 2011 with these vaccines are so encouraging that the Roswell Park Cancer Institute in New York joined the project and collaborates with the development and research of these Cuban vaccines.
To carry out the therapeutic treatment of lung cancer with the use of the therapeutic vaccine CIMAvax-EGF or Vaxira , the patient must ask us reach your request through our contact form .
In addition to the primary information, you must send us the histology and tumor stage via email, since treatment with the therapeutic vaccines CIMAvax-EGF or Vaxira is only registered for stage IIIb and advanced IV non-small cell lung cancer (NSCLC).
The qualified medical team will evaluate whether the patient is a candidate for treatment with these vaccines and receives it within a comprehensive care program for patients with lung cancer .
If accepted, you will be sent the medical program with the cost and time for which you must stay in Cuba for medical treatment
Transfer from Jóse Martí airport to La Pradera International Health Center (CIS La Pradera)
Transfer from La Pradera International Health Center (CIS La Pradera) to Jóse Martí airport at the end of the treatment
Hospitalization in a private room, with breakfast, lunch and dinner included.
Attention of the attending physician
Initial evaluation and preparation of the patient's medical history.
Request to be treated »